Veracyte is seeking an Executive Director of Discovery to drive the company's early-stage discovery engine, identifying and developing novel biomarkers, technologies, and platforms to transform cancer care. The role requires a strong track record in cancer biology, genomic technologies, and computational analysis, with a proven ability to translate complex biological signals into diagnostic product concepts.
Requirements
- Ph.D. in Molecular Biology, Cancer Biology, Genetics, Genomics, Bioinformatics, Computational Biology, or a related field
- 13+ years of experience in biotechnology, diagnostics, or academic cancer research with increasing scientific leadership responsibility
- Demonstrated track record of integrating experimental cancer biology with computational analytics to uncover clinically meaningful biomarkers
- Deep expertise in genetics and genomics, including NGS-based technologies, functional genomics assays, single-cell methods, or spatial profiling
- Proven ability to design and execute discovery programs that lead to molecular diagnostics or clinically actionable insights
- Hands-on leadership experience building and managing laboratory teams generating high-quality experimental data
- Proficiency in bioinformatics, statistical analysis, and modern machine-learning approaches
- Strong understanding of oncology disease mechanisms and the challenges inherent to developing diagnostic biomarkers
- Experience collaborating across R&D, clinical, regulatory, and product development functions
- Excellent leadership, communication, and interpersonal skills, with the ability to translate scientific discovery into strategic business value
Benefits
- Competitive compensation and benefits
- Discretionary bonuses/incentives, and restricted stock units